The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combination of everolimus with R-CHOP (ever R-CHOP) as an initial therapy for diffuse large B-cell lymphoma (DLBCL): A phase I and feasibility study (NCCTG N1085 [Alliance]).
 
Patrick B. Johnston
No Relationships to Disclose
 
Betsy LaPlant
No Relationships to Disclose
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene; MorphoSys
Research Funding - Celgene (Inst)
 
Ivana N. M. Micallef
No Relationships to Disclose
 
Stephen Maxted Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Bristol-Myers Squibb (Inst); Celldex (Inst); Seagen (Inst)
 
Thomas Matthew Habermann
No Relationships to Disclose
 
Joseph Colgan
No Relationships to Disclose
 
Thomas E. Witzig
Research Funding - Novartis (Inst)